熱門資訊> 正文
iMDx报告了与另一种市售测试套件进行正面比较的旗舰测试套件技术的研究结果。
2025-06-24 04:06
- MEDNAX, Inc.(MD) 0
- Ginkgo Bioworks Holdings, Inc. Class A Common Stock(DNA) 0
- Panasonic Holdings Corporation ADR(PC) 0
- Study indicates iMDx flagship technology's equivalence with commercially available dd-cfDNA test kits
- Head-to-head comparison of iMDx's digital PCR-based test kits with NGS kits shows consistent results in 96 transplant patients
- Data was presented at the European Renal Association (ERA) 2025
- Extended data to be presented at the European Society of Organ Transplantation (ESOT) Congress in London, June 29 – July 2
- Upcoming National Principal Investigator and Key Opinion Leader call planned
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
